SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of TrovaGene, Inc.

NEW YORK--()--Levi & Korsinsky announces it has commenced an investigation of TrovaGene, Inc. (“TrovaGene” or the “Company”) (NASDAQ:TROV) concerning possible violations of federal securities laws by certain officers and directors.

On March 28, 2016, TrovaGene announced that its Board of Directors had terminated the employment of CEO Antonius Schuh and CFO Stephen Zaniboni and filed a complaint against them for, among other allegations, breaches of fiduciary duty. To obtain additional information about the investigation, go to:

http://zlk.9nl.com/trovagene-trov

or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
Tel: 212-363-7500
Toll Free: 877-363-5972
Fax: 212-363-7171
www.zlk.com

Release Summary

Levi & Korsinsky announces it has commenced an investigation of TrovaGene, Inc. concerning possible violations of federal securities laws.

Contacts

Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
Tel: 212-363-7500
Toll Free: 877-363-5972
Fax: 212-363-7171
www.zlk.com